Biotech entity
Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention Department of Justice, the most common co-covered peer. Each carries 8 original sources on average. We currently track 1 Biotech story that mention Kash Patel, all published on March 25, 2026.
Last mentioned: Jul 11, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention Department of Justice, the most common co-covered peer. Each carries 8 original sources on average. We currently track 1 Biotech story that mention Kash Patel, all published on March 25, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 17 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Kash Patel. Shared-story counts are live from our verified record — not editorial picks.
The U.S. Department of Justice has unsealed indictments against several Chinese citizens and chemical companies for allegedly distributing precursor chemicals used in the illicit manufacture of fentanyl. This move signals an aggressive escalation in the federal government's strategy to dismantle the international supply chains fueling the American opioid epidemic.
Kash Patel is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
